BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7629996)

  • 1. [Abnormal E-cadherin expression as a risk factor for deep myometrial invasion and lymph node metastasis in endometrial carcinoma].
    Nomura E; Sakuragi N; Fujimoto S
    Nihon Rinsho; 1995 Jul; 53(7):1607-12. PubMed ID: 7629996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion.
    Sakuragi N; Nishiya M; Ikeda K; Ohkouch T; Furth EE; Hareyama H; Satoh C; Fujimoto S
    Gynecol Oncol; 1994 May; 53(2):183-9. PubMed ID: 8188077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.
    Frumovitz M; Slomovitz BM; Singh DK; Broaddus RR; Abrams J; Sun CC; Bevers M; Bodurka DC
    J Am Coll Surg; 2004 Sep; 199(3):388-93. PubMed ID: 15325608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
    Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
    Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
    Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
    Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
    Saito T; Nishimura M; Yamasaki H; Kudo R
    Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion.
    Takeshima N; Hirai Y; Tanaka N; Yamawaki T; Yamauchi K; Hasumi K
    Obstet Gynecol; 1996 Aug; 88(2):280-2. PubMed ID: 8692516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
    Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
    J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation.
    Nei H; Saito T; Tobioka H; Itoh E; Mori M; Kudo R
    Cancer; 1996 Aug; 78(3):461-70. PubMed ID: 8697392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
    Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.
    Kim JH; Park JM; Jung CW; Park SS; Kim SJ; Mok YJ; Kim CS; Chae YS; Bae JW
    J Surg Oncol; 2008 Feb; 97(2):125-30. PubMed ID: 18095267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.